DiaSorin | LinkedIn
Report on the Remuneration Policy
Homepage - DiaSorin Molecular
DiaSorin Spa Italy - DiaSorin Molecular
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
COVID-19 | Updates | DiaSorin
DiaSorin | Saluggia
Untitled
Annual Financial Report
ASSEMBLEA DEGLI AZIONISTI
LIAISON® XL | DiaSorin
DiaSorin - The Diagnostic Specialist
DiaSorin Molecular LLC | LinkedIn
DiaSorin - The Diagnostic Specialist
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
DiaSorin | LinkedIn
Relazione_CG_Esercizio_31 12 2008_en
 "DiaSorin simplifies diagnostics by implementing a digital solution | Reply")
DiaSorin simplifies diagnostics by implementing a digital solution | Reply
DiaSorin Molecular LLC | LinkedIn
LIAISON® XL | DiaSorin
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics
COVID-19 | Updates | DiaSorin
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
Annual Financial Report
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
DiaSorin | LinkedIn
DiaSorin concludes acquisition of Luminex for $1.8bn
Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays | Scientific Reports
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
Annual Financial Report
DiaSorin | Saluggia
DiaSorin to buy Luminex for $1.8B - MassDevice
Results | DiaSorin
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
DiaSorin Inc. | LinkedIn
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
DiaSorin Inc. | LinkedIn
DiaSorin | Saluggia
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin Inc. | DiaSorin
DiaSorin | Saluggia
DiaSorin - The Diagnostic Specialist
DiaSorin | Saluggia
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
Results | DiaSorin
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-
DiaSorin
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
